Age, Gvhd Prophylaxis, and Timing Matter in Thrombotic Microangiopathy after Hematopoietic Cell Transplantation- a Secondary CIBMTR Analysis

Hematopoietic cell transplantation associated thrombotic microangiopathy (TA-TMA) is associated with significant morbidity and mortality. Risk factors for developing TA-TMA and impact of TA-TMA on survival were published from a large Center for International Blood and Marrow Transplant Research (CIBMTR) (Epperla et al, BJH. 2020). We used this database to investigate whether there were different risk factors (RF) for developing TA-TMA in children and adults and identify prognostic factors, including timing of TA-TMA diagnosis.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Tags: 20 Source Type: research